Themis Medicare Limited informed that the wholly owned subsidiary of the Company in the name of "Rx Themis Private Limited" has been incorporated on 19 September, 2023. Industry to which the entity being acquired belongs: Manufacturing of Pharmaceuticals drugs including medicinal chemicals, fermentation products, natural products, synthetic products, feed supplements, cosmetics, etc. Cost of acquisition or the price at which the shares are acquired.: INR 100,000/- as Share Capital contribution.

% of shareholding/control acquired and/or number of shares acquired.: The Company owns 100% of the shareholding in the new entity viz. Rx Themis Private Limited.